Research programme: respiratory syncytial virus vaccine - AlphaVaxAlternative Names: RSV vaccine - AlphaVax; RSV-F vaccine - AlphaVax
Latest Information Update: 29 Oct 2013
At a glance
- Originator AlphaVax
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Respiratory syncytial virus infections
Most Recent Events
- 10 Nov 2012 Preclinical development is ongoing in USA
- 01 Dec 2010 Preclinical trials in Respiratory syncytial virus infections in USA (Parenteral)